Ticagrelor, marketed under brand names such as Brilinta® and Brilique®, is an oral, reversible P2Y12 adenosine diphosphate (ADP) receptor antagonist used to reduce thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) or those undergoing percutaneous coronary intervention …
We'll support you, anytime.